Keith Robison at Omics! Omics! points out a paper in PNAS in which Regeneron shows that a compound it developed called VEGF-Trap can be used to measure the amount of circulating VEGF (vascular endothelial growth factor) in blood. VEGF is a signaling molecule that stimulates angiogenesis, and is therefore used to determine dosage for drugs used to treat cancer.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.